Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Oct-24 4:48 PM View:  | Horn Howard Chief Financial Officer | Ultragenyx Pharmaceutical I... (RARE) | 10-Oct-24 | Sale | 7,465 | $52.76 | $393,853.00 | (7%) 99.77K to 92.3K | |
| 18-Sep-24 1:03 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 16-Sep-24 | Grant | 700 | -- | -- | 2% 41.55K to 42.25K | |
| 05-Sep-24 11:50 AM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 03-Sep-24 | Sale | 91 | $56.19 | $5,113.29 | (< 1%) 41.64K to 41.55K | |
| 05-Sep-24 11:53 AM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 03-Sep-24 | Sale | 20,000 | $55.85 | $1,117,000.00 | (< 1%) 2.81M to 2.79M | |
| 07-Aug-24 2:48 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 06-Aug-24 | Sale | 20,000 | $50.17 | $1,003,400.00 | (< 1%) 2.83M to 2.81M | |
| 03-Jul-24 2:07 PM View: | Sanders Corazon (corsee) D. Director | Ultragenyx Pharmaceutical I... (RARE) | 02-Jul-24 | Sale | 584 | $40.98 | $23,932.30 | (5%) 12.59K to 12.01K | |
| 20-Jun-24 2:22 PM View: | Sanders Corazon (corsee) D. Director | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 74% 7.25K to 12.59K | |
| 20-Jun-24 2:29 PM View: | Dunsire Deborah Director | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 27% 19.73K to 25.07K | |
| 20-Jun-24 2:24 PM View: | Narachi Michael Director | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 25% 21.61K to 26.95K | |
| 20-Jun-24 2:25 PM View: | Welch Daniel G Director | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 25% 21.61K to 26.95K | |
| 20-Jun-24 2:23 PM View: | Ray Amrit Director | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 44% 12.28K to 17.63K | |
| 20-Jun-24 2:22 PM View: | Suliman Shehnaaz Director | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 36% 14.86K to 20.2K | |
| 20-Jun-24 2:26 PM View: | Fust Matthew K Director | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 36% 14.86K to 20.2K | |
| 12-Jun-24 7:47 PM View: | Parschauer Karah Herdman EVP and Chief Legal Officer | Ultragenyx Pharmaceutical I... (RARE) | 12-Jun-24 | Sale | 9,806 | $45.00 | $441,270.00 | (14%) 67.79K to 57.98K | |
| 10-Jun-24 7:58 PM View: | Sanders Corazon (corsee) D. Director | Ultragenyx Pharmaceutical I... (RARE) | 10-Jun-24 | Sale | 1,737 | $41.10 | $71,390.70 | (19%) 8.98K to 7.25K | |
| 03-May-24 3:23 PM View: | Crombez Eric EVP and Chief Medical Officer | Ultragenyx Pharmaceutical I... (RARE) | 02-May-24 | Sale | 354 | $43.66 | $15,455.60 | (< 1%) 48.78K to 48.43K | |
| 19-Apr-24 4:35 PM View: | Crombez Eric EVP and Chief Medical Officer | Ultragenyx Pharmaceutical I... (RARE) | 18-Apr-24 | Sale | 142 | $44.10 | $6,262.20 | (< 1%) 48.93K to 48.78K | |
| 18-Apr-24 6:06 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 16-Apr-24 | Payment of Exercise | 14 | $42.31 | $592.34 | (< 1%) 41.38K to 41.37K | |
| 12-Mar-24 1:41 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 11-Mar-24 | Sale | 11,509 | $49.93 | $574,644.00 | (4%) 264.33K to 252.82K | |
| 11-Mar-24 12:54 PM View: | Fust Matthew K Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Mar-24 | Sale | 12,195 | $50.88 | $620,443.00 | (45%) 27.05K to 14.86K | |
| 05-Mar-24 8:13 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 13,950 | -- | -- | 50% 27.89K to 41.84K | |
| 05-Mar-24 8:08 PM View: | Harris Erik EVP & Chief Commercial Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 4,768 | $53.76 | $256,328.00 | (7%) 71.93K to 67.16K | |
| 05-Mar-24 8:06 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 41,560 | -- | -- | 1% 2.8M to 2.85M | |
| 05-Mar-24 8:19 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 1,011 | $53.76 | $54,351.40 | (< 1%) 265.34K to 264.33K | |
| 05-Mar-24 8:15 PM View: | Pinion John Richard See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 25% 74.74K to 93.5K | |
| 05-Mar-24 8:22 PM View: | Parschauer Karah Herdman EVP and Chief Legal Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 36% 52.34K to 71.1K | |
| 05-Mar-24 8:17 PM View: | Huang Dennis Karl See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 470 | $53.69 | $25,234.30 | (< 1%) 83.47K to 83.0K | |
| 05-Mar-24 8:13 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 121 | $53.69 | $6,496.49 | (< 1%) 41.84K to 41.72K | |
| 05-Mar-24 8:13 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 341 | $53.76 | $18,332.20 | (< 1%) 41.72K to 41.38K | |
| 05-Mar-24 8:10 PM View: | Crombez Eric EVP and Chief Medical Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 19,400 | -- | -- | 63% 30.77K to 50.16K | |
| 05-Mar-24 8:19 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 8% 246.86K to 265.62K | |
| 05-Mar-24 8:06 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 17,417 | $53.69 | $935,119.00 | (< 1%) 2.85M to 2.83M | |
| 05-Mar-24 8:15 PM View: | Pinion John Richard See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 60 | $53.69 | $3,221.40 | (< 1%) 93.5K to 93.44K | |
| 05-Mar-24 8:22 PM View: | Parschauer Karah Herdman EVP and Chief Legal Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 3,756 | $53.76 | $201,923.00 | (5%) 71.1K to 67.34K | |
| 05-Mar-24 8:10 PM View: | Crombez Eric EVP and Chief Medical Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 1,238 | $53.76 | $66,554.90 | (2%) 50.16K to 48.93K | |
| 05-Mar-24 8:08 PM View: | Harris Erik EVP & Chief Commercial Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 20,357 | -- | -- | 39% 51.57K to 71.93K | |
| 05-Mar-24 8:23 PM View: | Horn Howard Chief Financial Officer | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 19,400 | -- | -- | 24% 80.37K to 99.77K | |
| 05-Mar-24 8:19 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Payment of Exercise | 274 | $53.69 | $14,711.10 | (< 1%) 265.62K to 265.34K | |
| 05-Mar-24 8:15 PM View: | Pinion John Richard See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 4,173 | $53.76 | $224,340.00 | (4%) 93.44K to 89.27K | |
| 05-Mar-24 8:17 PM View: | Huang Dennis Karl See Remarks | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 29% 64.72K to 83.47K | |
| 08-Feb-24 3:49 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 07-Feb-24 | Sale (Planned) | 30,000 | $45.00 | $1,350,000.00 | (1%) 2.83M to 2.8M | |
| 02-Jan-24 4:06 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 02-Jan-24 | Option Exercise | 3,000 | $21.00 | $63,000.00 | 12% 24.89K to 27.89K | |
| 02-Jan-24 4:07 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 29-Dec-23 | Sale (Planned) | 30,000 | $47.87 | $1,436,100.00 | (1%) 2.86M to 2.83M | |
| 02-Jan-24 4:06 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 20-Dec-23 | Grant | 1,000 | -- | -- | 4% 23.61K to 24.61K | |
| 24-Oct-23 5:22 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 23-Oct-23 | Option Sale | 39,878 | $32.78 | $1,307,200.00 | (14%) 286.74K to 246.86K | |
| 24-Oct-23 5:22 PM View: | Kassberg Thomas Richard CBO & EVP | Ultragenyx Pharmaceutical I... (RARE) | 23-Oct-23 | Option Exercise | 39,878 | $6.86 | $273,563.00 | 16% 246.86K to 286.74K | |
| 23-Oct-23 5:14 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 19-Oct-23 | Option Exercise | 47,853 | $6.86 | $328,272.00 | 2% 2.86M to 2.91M | |
| 23-Oct-23 5:14 PM View: | Kakkis Emil D President & CEO Director | Ultragenyx Pharmaceutical I... (RARE) | 19-Oct-23 | Option Sale | 47,853 | $33.52 | $1,604,030.00 | (2%) 2.91M to 2.86M | |
| 11-Sep-23 1:52 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 07-Sep-23 | Sale | 163 | $40.80 | $6,650.33 | (< 1%) 23.78K to 23.61K | |
| 11-Sep-23 1:52 PM View: | Huizenga Theodore Alan SVP, Chief Accounting Officer | Ultragenyx Pharmaceutical I... (RARE) | 07-Sep-23 | Option Exercise | 2,000 | $21.00 | $42,000.00 | 8% 23.78K to 25.78K |
